ArticleAddiction science & clinical practice2026
"I really can't imagine anything that could've been more easy": patient perspectives on low-threshold peer-facilitated telemedicine hepatitis C treatment for people who use drugs.
Article in Addiction science & clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundInjection drug use among nonurban people has fueled sharp rises in Hepatitis C (HCV) infections. Innovative treatment models are needed that circumvent healthcare system barriers for people who use drugs (PWUD), particularly in rural areas. The Oregon HOPE TeleHCV study randomized PWUD living with HCV in rural Oregon to peer-facilitated and streamlined telemedicine HCV treatment (Peer TeleHCV) versus enhanced usual care (EUC) and assessed sustained virologic response at 12 weeks post treatment (SVR12). Peer Support Specialists (peers) conducted HCV screening in the community, facilitated pretreatment evaluation and linkage to telemedicine HCV treatment clinicians, and supported participants in HCV medication adherence. A qualitative investigation queried patients about their experiences with the implementation of the model.
methodsThis qualitative study explored patient experiences with the Peer TeleHCV model in rural Oregon. We conducted semi-structured interviews with 34 participants purposively sampled from a larger randomized trial comparing Peer TeleHCV with enhanced usual care. The qualitative team analyzed transcripts using a thematic analysis framework combining inductive and deductive coding.
resultsParticipants described the model as accessible, supportive, and low barrier. We identified three major themes: 1) Staff approach and values facilitated engagement in care; 2) Convenience and flexibility made care accessible, and 3) Support addressing needs helped overcome barriers to care.
conclusionFindings highlight how community-based peers, integrated telemedicine, and flexible model design together reduce structural barriers to HCV care for rural PWUD. Adapting peer-facilitated telemedicine models can inform broader implementation of low-threshold, equitable approaches for substance use disorders and infectious disease treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.